ATTR amyloidosis results from the buildup of transthyretin in the body. It can be inherited or acquired and can affect your heart, kidneys, and nervous system. While there’s no cure, treatment can ...

Novo Nordisk has struck a $1.2 billion deal to buy Prothena’s ATTR amyloidosis program, which was stalled by the pandemic last year. The deal will see Novo pay $100 million in upfront and near-term ...

Transthyretin amyloidosis (ATTR) is not one disease, but a cluster of related conditions. At their core, they stem from a disorder that develops when normal proteins produced by the liver suddenly ...